FDA expanding access to pancreatic cancer drug to some patients




FDA expanding access to pancreatic cancer drug to some patients – CBS News










































Watch CBS News



The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *